MX9204913A - Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen. - Google Patents

Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen.

Info

Publication number
MX9204913A
MX9204913A MX9204913A MX9204913A MX9204913A MX 9204913 A MX9204913 A MX 9204913A MX 9204913 A MX9204913 A MX 9204913A MX 9204913 A MX9204913 A MX 9204913A MX 9204913 A MX9204913 A MX 9204913A
Authority
MX
Mexico
Prior art keywords
substituted
quinolylmetoxy
phenylcetamides
heterociclicamente
procedure
Prior art date
Application number
MX9204913A
Other languages
English (en)
Inventor
Siegfried Raddatz
Klaus-Helmut Mohrs
Michael Matzke
Romanis Fruchtmann
Armin Hatzelmann
Christian Kohlsdorfer
Reiner Muller-Peddinghaus
Pia Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX9204913A publication Critical patent/MX9204913A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9204913A 1991-09-06 1992-08-26 Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen. MX9204913A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4129742A DE4129742A1 (de) 1991-09-06 1991-09-06 Heterocyclisch substituierte chinolylmethoxy-phenylacetamide

Publications (1)

Publication Number Publication Date
MX9204913A true MX9204913A (es) 1993-03-01

Family

ID=6440067

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204913A MX9204913A (es) 1991-09-06 1992-08-26 Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen.

Country Status (19)

Country Link
US (1) US5266578A (es)
EP (1) EP0530639B1 (es)
JP (1) JPH05194403A (es)
KR (1) KR930006004A (es)
CN (1) CN1070190A (es)
AT (1) ATE110070T1 (es)
AU (1) AU649351B2 (es)
CA (1) CA2077465A1 (es)
CZ (1) CZ276092A3 (es)
DE (2) DE4129742A1 (es)
DK (1) DK0530639T3 (es)
ES (1) ES2057953T3 (es)
FI (1) FI923968A (es)
HU (1) HUT65660A (es)
IL (1) IL103040A0 (es)
MX (1) MX9204913A (es)
NO (1) NO923181L (es)
NZ (1) NZ244225A (es)
TW (1) TW221431B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
ES2103180B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Fenilacetamidas con accion antagonista de los leucotrienos.
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
EP0725063A1 (de) * 1995-02-01 1996-08-07 Ciba-Geigy Ag Chinolin-Derivate
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US6399641B1 (en) * 2000-07-13 2002-06-04 Hoffmann-La Roche Inc. 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
MXPA06002567A (es) * 2003-09-06 2006-09-04 Vertex Pharma Moduladores de transportadores con casete de union de atp.
KR102393675B1 (ko) * 2021-08-20 2022-05-11 (주)삼우공간건축사사무소 공동주택용 세대현관의 안전바닥패널

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU612569B2 (en) * 1986-03-13 1991-07-18 Rorer International (Overseas) Inc. Quinolinyl ether or thioether tetrazoles as agents for the treatment of hypersensitive ailments
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5102881A (en) * 1988-06-27 1992-04-07 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5041453A (en) * 1990-05-30 1991-08-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4

Also Published As

Publication number Publication date
CA2077465A1 (en) 1993-03-07
ATE110070T1 (de) 1994-09-15
JPH05194403A (ja) 1993-08-03
AU2205492A (en) 1993-03-11
NZ244225A (en) 1994-08-26
EP0530639A1 (de) 1993-03-10
FI923968A0 (fi) 1992-09-04
DE59200387D1 (de) 1994-09-22
ES2057953T3 (es) 1994-10-16
CN1070190A (zh) 1993-03-24
AU649351B2 (en) 1994-05-19
CZ276092A3 (en) 1993-06-16
KR930006004A (ko) 1993-04-20
HU9202850D0 (en) 1992-11-30
HUT65660A (en) 1994-07-28
FI923968A (fi) 1993-03-07
IL103040A0 (en) 1993-02-21
US5266578A (en) 1993-11-30
NO923181L (no) 1993-03-08
NO923181D0 (no) 1992-08-14
DE4129742A1 (de) 1993-03-11
EP0530639B1 (de) 1994-08-17
DK0530639T3 (da) 1994-12-05
TW221431B (es) 1994-03-01

Similar Documents

Publication Publication Date Title
ES2102367T3 (es) Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
PT91158A (pt) Processo para a preparacao de novos estirenos e carboxamidas heterociclicos biciclicos e composicoes farmaceuticas que os contem
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
NO940277L (no) Triglycerider og blandinger av slike
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ATE88183T1 (de) Substituierte 4-(chinolin-2-yl-methoxy)phenylessigs|ure-derivate.
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
AR024944A1 (es) Amidas de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y su preparacion
ES2077199T3 (es) Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
MX9202982A (es) Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen.
MX9201356A (es) Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
MX9204913A (es) Quinolilmetoxi-fenilcetamidas substituidas heterociclicamente, procedimiento para su fabricacion y medicamentos que las contienen.
ATE164159T1 (de) Substituierte triole
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
MX9204031A (es) Sal de l-ascorbato de 16-descarboxi-16-hidroximetil-amfotericina b, proceso para su preparacion y composicion farmaceutica que contiene dicha sal.
DE69420961D1 (de) Zusammensetzungen zur duftfreisetzung die geringe mengen von fluechtigen organischen komponenten enthalten
MX9205132A (es) Derivados de acidos carboxilicos heterociclicos, procedimiento para su obtencion y medicamentos que los contienen.
ES2096727T5 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
DK0391185T3 (da) 1,8-Naphthyridiner
SE7612860L (sv) Deoderant
MX9201482A (es) Acidos carboxilicos opticamente activos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
MX9204035A (es) Composiciones liquidas que contienen esteres carboxilicos organicos.